Increased epicardial adipose tissue in type 1 diabetes is associated with central obesity and metabolic syndrome

Diabetes Research and Clinical Practice

Volumn 91, Issue 1, 2011, Pages 47-53

  Momesso, Denise Prado ^a   Bussade, Isabela ^a   Epifanio, Marcio Antonio ^b   Schettino, Claudio Domenico Sahione ^b   Russo, Luis Augusto Tavares ^c   Kupfer, Rosane ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Gaveacor Diagnóstico Cardiológico   (Brazil)

^c CCBR Brasil   (Brazil)

Author keywords

Body fat composition; Epicardial adipose tissue; Metabolic syndrome; Type 1 diabetes

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY FAT DISTRIBUTION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EPICARDIUM; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC SYNDROME X; MICROALBUMINURIA; OBESITY; PREDICTION; WAIST HIP RATIO;

ABSORPTIOMETRY, PHOTON; ADIPOSITY; ADULT; BIOLOGICAL MARKERS; BODY FAT DISTRIBUTION; BODY MASS INDEX; BRAZIL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; INTRA-ABDOMINAL FAT; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; PERICARDIUM; RISK FACTORS;

EID: 78650573549     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.09.037     Document Type: Article

References (45)

1. Soedamah-Muthu S.S., Fuller J.H., Mulnier H.E., Raleigh V.S., Lawrenson R.A., Colhoun H.M. All cause mortality rates in patients with type 1 diabetes mellitus compared with non-diabetic population from UK general practice research database, 1992-1999. Diabetologia 2006, 49:660-666.
2. Soedamah-Muthu S.S., Fuller J.H., Mulnier H.E., Raleigh V.S., Lawrenson R.A., Colhoun H.M. High risk of cardiovascular disease in patients with type 1 diabetes in UK. Diabetes Care 2006, 29:798-804.
3. Laing S.P., Swerdlow A.J., Slater S.D., Burden A.C., Morris A., Waugh N.R., et al. Mortality from heart disease in a cohort of 23000 patients with insulin-treated diabetes. Diabetologia 2003, 46:760-765.
4. Orchard T.J., Costacou T., Kretowski A., Nesto R.W. Type 1 diabetes and coronary disease. Diabetes Care 2006, 29:2528-2538.
5. Thorn L.M., Forsblom C., Fegerudd J., Thomas M.C., Petterson-Fernholm K., Saraheimo M., et al. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 2005, 28:2019-2024.
6. Pambianco G., Costacou T., Orchard T.J. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate. Diabetes Care 2007, 30:1248-1254.
7. Kilpatrick E.S., Rigby A.S., Atkin S.L. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the diabetes control and complications trial. Diabetes Care 2007, 30:707-712.
8. McGill M., Molyneaux L., Twigg S.M., Yue D.K. The metabolic syndrome in type 1 diabetes: does it exist and does it matter?. J Diab Comp 2008, 22:18-23.
9. Davis T.M.E., Bruce D.G., Davis W.A. Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract 2007, 78:412-417.
10. Isomaa B., Almgren P., Tiinamaija T., Forsén B., Lahti K., Nissén M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689.
11. Reaven G.M. Role of insulin resistance in human disease (syndrome X): an expanded definition. Ann Rev Med 1993, 44:121-131.
12. Balkau B., Charles M.A. Comment on the provisional report from the WHO consultation. European group for the study of insulin resistance (EGIR). Diabet Med 1999, 16:442-443.
13. Laaksonen D.E., Lakka H.M., Niskanen L., Kaplan G.A., Salonen J.T., Lakka T.A. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemil 2002, 156:1070-1077.
14. Kissebah A.H., Vydelingum N., Murray R., Evans D.J., Hartz A.J., Kalkhoff R.K., et al. Relation of body fat distribution to metabolic complication of obesity. J Clin Endocrinol Metab 1982, 54:254-260.
15. Fujioka S., Matsuzawa Y., Tokunaga K., Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987, 36:54-59.
16. Iacobellis G., Ribaudo M.C., Assael F., Vecci E., Tiberti C., Zappaterreno A., et al. Echocardiographic epicardial adipose tissue is related to antropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003, 88:5163-5168.
17. Iacobellis G., Assael F., Ribaudo M.C., Zappaterreno A., Alessi G., Di Mario U., et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003, 11:304-310.
18. Silaghi A., Piercecchi-Marti M.D., Grino M., Leonetti G., Alessi M.C., Clement K., et al. Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy. Obesity 2008, 16:2424-2430.
19. Iacobellis G., Pellicelli A.M., Grisorio B., Barbarini G., Leonetti F., Sharma A.M., et al. Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat. Obesity 2008, 16:179-183.
20. Jeong J.W., Jeong M.H., Yun K.H., Oh S.K., Park E.M., Kim Y.K., et al. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 2007, 71:536-539.
21. Chaowalit N., Somers V.K., Pellikka P.A., Rihal C.S., Lopez-Jimenez F. Adipose tissue of atrium septum as a marker of coronary artery disease. Chest 2007, 132:817-822.
22. Ahn S.G., Lim H.S., Joe D.Y., Kang S.J., Choi S.Y., Choi B.J., et al. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart 2008, 94:e7.
23. Eroglu S., Sade L.E., Yildirir A., Bal U., Ozbicer S., Ozgul A.S., et al. Epicardial adipose tissue thickness by echocardiography is a marker of the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis 2009, 19:211-217.
24. Djaberi R., Schuiif J.D., vanWerkhoven J.M., Nucifora G., Jukema J.W., Bax J.J. Relation of epicardial adipose tissue to coronary atherosclerosis. Am J Cardiol 2008, 102:1602-1607.
25. Ueno K., Anzai T., Jinzaki M., Yamada M., Jo Y., Maekawa Y., et al. Increased epicardial fat volume quantified by 64-multidetector computed tomography is associated with coronary atherosclerosis and totally occlusive lesions. Circ J 2009, 73:1927-1933.
26. Wang C.P., Hsu H.L., Hung W.C., Yu T.H., Chen Yh, Chiu C.A., et al. Increased epicardial adipose tissue volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol 2009, 70:876-882.
27. Friedwald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low lipoprotein colesterol in plasma without use of preparative centrifugation. Clin Chem 1972, 18:499-502.
28. Mazess R.B., Barden H.S., Bisek J.P., Hanson J. Dual-X-ray-absorptiometry for total body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 1990, 51:1106-1112.
29. Prior B.M., Cureton K.J., Modlesky C.M., Evans E.M., Sloniger M.A., Saunders M., et al. In vivo validation of whole body composition estimates from dual-energy X-ray absorptiometry. J Appl Physiol 1997, 83:623-630.
30. Clasey J.L., Bouchard C., Teates C.D. The use of anthropometric and dual-energy X-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women. Obes Res 1999, 7:256-264.
31. Park Y.W., Hemsfield S.B., Gallagher D. Are dual-energy X-ray absorptiometry regional estimates associated with visceral adipose tissue mass?. Int J Obes Relat Metab Disord 2002, 26:978-983.
32. Norcross J., Van Loan M.D. Validation of fat beam dual energy X-ray absorptiometry for body composition assessment in adults aged 18-45 years. Br J Sports Med 2004, 38:472-476.
33. Lee C.C., Glickman S.G., Dengel D.R., Brown M.D., Supiano M.A. Abdominal adiposity assessed by dual energy X-ray absorptiometry provides a sex-independent predictor of insulin sensitivity in older adults. J Gerontol A Biol Sci Med Sci 2005, 60:872-878.
34. Talbott E.O., Zborowski J., Rager J., Stragand J.R. Is there an independent effect of polycystic ovary syndrome and menopause on the prevalence of subclinical atherosclerosis in middle aged women?. Vasc Health Risk Manage 2008, 4:453-462.
35. Guthrie J.R., Taffe J.R., Lehert P., Burger H.G., Dennerstein L. Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study. Menopause 2004, 11:315-322.
36. Shister L.T, Rhodes D.J., Gostout B.S., Grossardt B.R., Rocca W.A. Premature menopause or early menopause: long term health consequences. Maturitas 2010, 65:161-166.
37. Ho S.C., Wu S., Chan S.G., Sham A. Menopausal transition and changes of body composition: a prospective study in Chinese perimenopausal women. Int J Obes (Lond) 2010, 34:1265-1274.
38. Genazzani A.R., Gambacciani M. Effect of climateric transition and hormone replacement therapy on body weight and body fat distribution. Gynecol Endocrinol 2006, 22:145-150.
39. Carmina E, Bucchieri S., Esposito A., Del Puente A., Mansueto P., Orio F., et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 2007, 92:2500-2505.
40. Santos C.E., Schrank Y., Kupfer R. Critical analyses of WHO, IDF and NCEP criteria for metabolic syndrome among patients with type 1 diabetes mellitus. Arq Bras Endocrinol Metab 2009, 53:1096-1102.
41. Liu J., Fox C.S., Hickson D.A., May W.D., Hairston K.G., et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the jackson heart study. J Clin Endocrinol Metab 2010, [September 15, Epub ahead of print].
42. Iacobellis G., Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab 2005, 90:6300-6302.
43. Baker A.R., Harte A.L., Howell N., Pritlove D.C., Ranasinghe A.M., da Silva N.F., et al. Epicardial adipose tissue as a source of nuclear factor-kb and c-jun n-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab 2009, 94:261-267.
44. Baker A.R., da Silva N.F., Quinn D.W., Harte A.L., Pagano D., Bonser R.S., et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006, 5:1-7.
45. Iacobellis G., Willens H.J., Barbaro G., Sharma A.M. Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity 2008, 16:887-892.